|
| |
Alpha Therapeutic mitsubishi Pages on BioPortfolio:
BioPortfolio - Alpha Therapeutic Corporation
11 Nov 2008 ... In 1978, it was incorporated in California as Alpha Therapeutic Corporation. Alpha's parent company, Mitsubishi Pharma Corporation, ...
http://www.bioportfolio.com/biocorporate/595-Alpha_Therapeut...
|
BioPortfolio - Alpha Therapeutic Corporation - Profile
1978, it was incorporated in California as Alpha Therapeutic Corporation. Alpha's parent company, Mitsubishi. Pharma Corporation, is traded on the
Japanese ...
http://www.bioportfolio.com/biocorporate/595-Alpha%2BTherape...
|
BioPortfolio - Mhi - Profile
Reaching the therapeutic goal in hypertension: results from the Canadian valsartan ... Department of Orthopaedic Surgery, Mitsubishi Nagoya Hospital, ...
http://www.bioportfolio.com/biocorporate/34563-Mhi.pdf...
|
Blood: The Worldwide Market for Blood Products, Blood Testing ...
... Complex Factor VIIa Fibrin/Thrombin Therapeutic Apheresis Blood Management ... Albumin Market Size Prothrombin Complex Concentrates Alpha-1 Proteinase ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_47.html...
|
BioPortfolio - Mitsui Norin Co Limited - Profile
Therapeutics Daily: Oct 6 2008 11:17AM Matching: mitsui ... 5318986- Method of inhibiting the activity of .alpha.-amylase. • 5204089- Method of preventing ...
http://www.bioportfolio.com/biocorporate/7149-Mitsui%252BNor...
|
HMP-12 an adrenoceptor antagonist for the treatment of male and ...
HMP-12 therefore offers excellent therapeutic and commercial prospects and ...... Merck KGaA; Mitsubishi Pharma; Molecular Design; Nastech; NexMed; NicOx;
...
http://www.bioportfolio.com/LeadDiscovery/mdi002.htm...
|
BioPortfolio Client Press Releases Site Map
Biotech Tracker: Neuroimmunophilin Ligands Still Need to Demonstrate Therapeutic Effect · SCYNEXIS signs a drug discovery deal with Mitsubishi Pharma ...
http://www.bioportfolio.com/news/site_map.htm...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
Drug Discovery · Drug News by tradename(A-Z) · Drug Search by tradename (A-Z) · Daily Updates · Therapeutic Advances · Executive Reports · Drug Development ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - Alpha Therapeutic Corporation - Profile
1978, it was incorporated in California as Alpha Therapeutic Corporation. Alpha's parent company, Mitsubishi. Pharma Corporation, is traded on the
Japanese ...
http://www.bioportfolio.com/biocorporate/595-Alpha%2BTherape...
|
12-19-02 Baxter to Acquire Alpha 1 Antitrypsin
Alpha Therapeutic Corporation is owned by Mitsubishi Pharma Corporation. Under the agreement, Baxter will obtain Alpha Therapeutic Corporation's Alpha-1 ...
http://www.baxter.com/about_baxter/news_room/news_releases/2...
|
BioPortfolio - Alpha Therapeutic Corporation
11 Nov 2008 ... In 1978, it was incorporated in California as Alpha Therapeutic Corporation. Alpha's parent company, Mitsubishi Pharma Corporation, ...
http://www.bioportfolio.com/biocorporate/595-Alpha_Therapeut...
|
Ecraprost: AS 013, Circulase.
Alpha Therapeutic Corporation (a former subsidiary of Mitsubishi Pharma) was initially involved in trials of ecraprost in the US, but this responsibility ...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...
|
Grifols
Probitas Pharma buys assets from Alpha Therapeutic Corporation ... in Los Angeles belonging to the American subsidiary of Mitsubishi Pharma Corporation
...
http://www.grifols.com/web/noticias2.asp?idNoticia=10&seccio...
|
Jones Day - Professionals - Michael Sennett
Before the Federal Trade Commission and globally in the successful clearance of its acquisition of certain assets of Mitsubishi Pharma and Alpha Therapeutic ...
http://www.jonesday.com/lawyers/bio.aspx?attorneyID=S3461&op...
|
Grifols
The purchase of assets from Alpha Therapeutic Corporation, the North American affiliate of the Japanese Mitsubishi Pharma Corporation, in July 2003 has ...
http://www.grifols.com/web/noticias2.asp?idNoticia=30&seccio...
|
Therapeutic administration of Y-40138, a multiple cytokine ...
Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, ... Y-40138 may be expected as a new class of therapeutic drug for treatment of TNF-alpha,
...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...
|
A N N U A L R E P O R T 2 0 0 3
purchase of some of the assets of Alpha Therapeutic Corporation (the North American subsidiary of Mitsubishi Pharma. Corporation) in the United States and
...
http://www.grifols.com/investor_relations/eng/pdf/2003annual...
|
Synthetic alpha-mannosyl ceramide as a potent stimulant for an NKT ...
Developmental Immunology Unit, Mitsubishi Kagaku Institute of Life Sciences, ... regulation of the immune system and, thus, is a major therapeutic target. ...
http://www.ncbi.nlm.nih.gov/pubmed/15975513...
|
|
